Patent ID: 7790863
Filing Date: 2010-09-07
Classification: A61K,A61P,C07K,G01N

Abstract:
1. A labeled angiogenesis inhibiting molecule comprising a label and an angiogenesis inhibiting molecule selected from: (a) the antibody H33, produced by hybridoma 13H33 as deposited with the Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH under the deposit accession number DSM ACC2622, or antigen binding fragments thereof; (b) a humanized antibody comprising all of the complementarity determining regions (CDRs) of the H33 antibody; (c) a chimeric antibody comprising all of the CDRs of the H33 antibody; (d) a fragment of H33 selected from: (e) a recombinant antibody comprising all of the CDRs of the H33 antibody.